Diabetes in mice with monogenic obesity: The db/db mouse and its use in the study of cardiac consequences

Methods in Molecular Biology

Volumn 933, Issue , 2012, Pages 47-57

  Belke, Darrell D ^a   Severson, David L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bioenergetics; Cardiomyocytes; Echocardiography; Hyperinsulinemia; Leptin; Magnetic resonance imaging; Obesity; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE;

AEROBIC METABOLISM; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DB DB MOUSE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; HEART CONTRACTION; HEART MUSCLE CELL; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MONOGENIC DISORDER; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 84934442459     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-68-7_4     Document Type: Article

References (49)

1. Hummel KP, Dickie MM, Coleman DL (1966) Diabetes, a new mutation in the mouse. Science 153:1127-1128
2. Coleman DL (1982) Diabetes-obesity syndromes in mice. Diabetes 31:1-6
3. Wyse BM, Dulin WE (1970) The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia 6:268-273
4. Coleman DL, Hummel KP (1974) Hyperinsulinemia in pre-weaning diabetes ( db ) mice. Diabetologia 10:607-610
5. Aasum E, Hafstad AD, Severson DL et al (2003) Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52:434-441
6. Hummel KP, Coleman DL, Lane PW (1972) The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL/KsJ and C57BL/6J strains. Biochem Genet 7:1-13
7. Cavaghan MK, Ehrmann DA, Polonsky KS (2000) Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106: 329-333
8. Leibel RL, Chung WK, Chua SC Jr (1997) The molecular genetics of rodent single gene obesities. J Biol Chem 272:31937-31940
9. Garcia MJ, McNamara PM, Gordon T et al (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen year follow- up study. Diabetes 23:105-111
10. Grundy SM, Benjamin IJ, Burke GL et al (1999) Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146
11. Haffner SM, Lehto S, Ronnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
12. Lee C, Folsom A, Pankow J et al (2004) Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 109:855-860
13. Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595-602
14. Regan TJ, Lyons MM, Ahmed SS et al (1977) Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60:885-899
15. Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223
16. Tomlinson KC, Gardiner SM, Hebden RA et al (1992) Functional consequences of streptozotocin- induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103-179
17. Severson DL (2004) Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82:813-823
18. Kobayashi Y, Fortre TM, Taniguchi S et al (2000) The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49:22-31
19. Nishina PM, Naggert JK, Verstuyft J et al (1994) Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43:554-558
20. Jones SP, Girod WG, Granger DN et al (1999) Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol Heart Circ Physiol 277:H763-H769
21. Giacomelli F, Wiener J (1979) Primary myocardial disease in the diabetic mouse. An ultrastructural study. Lab Invest 40:460-473
22. Carley AN, Severson DL (2005) Review. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734:112-126
23. Semeniuk LM, Kryski AJ, Severson DL (2000) Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db - hGLUT4 mice. Am J Physiol Heart Circ Physiol 283:H976-H982
24. Stolen TO, Hoydal MA, Kemi OJ et al (2009) Interval training normalizes cardiomyocyte function, diastolic Ca 2+ control, and SR Ca 2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 105:527-536
25. Greer JJ, Ware DP, Lefer DJ (2006) Myocardial infarction and heart failure in the db/db diabetic mouse. Am J Physiol Heart Circ Physiol 290:H146-H153
26. Carley AN, Semeniuk LM, Shimoni Y et al (2004) Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286:E449-E455
27. Pereira L, Matthes J, Schuster I et al (2006) Mechanisms of (Ca 2+ )i transient decrease in cardiomyopathy of db/db type 2 diabetic mice. Diabetes 55:608-615
28. Daniels A, van Bilsen M, Janssen BJ et al (2010) Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodeling. Acta Physiol (Oxf) 200:11-22
29. Dong F, Ren J (2009) Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity (Silver Spring) 17:262-268
30. Yue P, Arai T, Terashima M et al (2007) Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse. Am J Physiol Heart Circ Physiol 292: H2106-H2118
31. Nielsen JM, Kristiansen SB, Norregaard R et al (2009) Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice. Eur J Heart Fail 11:638-647
32. Stuckey DJ, Carr CA, Tyler DJ et al (2008) Novel MRI method to detect altered left ventricular ejection and filling patterns in rodent models of disease. Magn Reson Med 60:582-587
33. Buchanan J, Mazumder PK, Hu P et al (2005) Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146:5341-5349
34. Aasum E, Cooper M, Severson DL et al (2005) Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice. Can J Physiol Pharmacol 83:183-190
35. Belke DD, Swanson EA, Dillmann WH (2004) Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53:3201-3208
36. Belke DD, Larsen TS, Gibbs EM et al (2000) Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic ( db/db ) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113
37. Kralik PM, Ye G, Metreveli NS et al (2005) Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes. Cardiovasc Toxicol 5:285-292
38. Trost SU, Belke DD, Bluhm WF et al (2002) Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51:1166-1171
39. Hafstad AD, Solevg GH, Severson DL et al (2006) Perfused hearts from Type 2 diabetic ( db/db ) mice show metabolic responsiveness to insulin. Am J Physiol Heart Circ Physiol 290:H1763-H1769
40. Carroll R, Carley AN, Dyck JRB et al (2005) Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am J Physiol Endocrinol Metab 288: E900-E906
41. An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489-H1506
42. Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes. Part I: general concepts. Circulation 105:1727-1733
43. Young ME, McNulty P, Taegtmeyer H (2002) Adaptation and maladaptation of the heart in diabetes. Part II: potential mechanisms. Circulation 105:1861-1870
44. Suga H (1990) Ventricular energetics. Physiol Rev 70:247-277
45. How O-J, Aasum E, Kunnathu S et al (2005) Influence of substrate supply on cardiac ef iciency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol 288:H2979-H2985
46. How O-J, Aasum E, Severson DL et al (2006) Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55:466-473
47. Boardman N, Hafstad AD, Larsen TS et al (2009) Increased O 2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice. Am J Physiol Heart Circ Physiol 296:H1373-H1379
48. Hafstad AD, Khalid AM, How O-J et al (2007) Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic ( db/db ) mice. Am J Physiol Endocrinol Metab 292:E1288-E1294
49. How O-J, Larsen TS, Hafstad AD et al (2007) Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice. Arch Physiol Biochem 113:211-220